199 related articles for article (PubMed ID: 12163367)
1. 5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue.
Hennig R; Ding XZ; Tong WG; Schneider MB; Standop J; Friess H; Büchler MW; Pour PM; Adrian TE
Am J Pathol; 2002 Aug; 161(2):421-8. PubMed ID: 12163367
[TBL] [Abstract][Full Text] [Related]
2. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
Ding XZ; Iversen P; Cluck MW; Knezetic JA; Adrian TE
Biochem Biophys Res Commun; 1999 Jul; 261(1):218-23. PubMed ID: 10405349
[TBL] [Abstract][Full Text] [Related]
3. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Tong WG; Ding XZ; Hennig R; Witt RC; Standop J; Pour PM; Adrian TE
Clin Cancer Res; 2002 Oct; 8(10):3232-42. PubMed ID: 12374694
[TBL] [Abstract][Full Text] [Related]
4. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention.
Hoque A; Lippman SM; Wu TT; Xu Y; Liang ZD; Swisher S; Zhang H; Cao L; Ajani JA; Xu XC
Carcinogenesis; 2005 Apr; 26(4):785-91. PubMed ID: 15661803
[TBL] [Abstract][Full Text] [Related]
5. Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells.
Ding XZ; Kuszynski CA; El-Metwally TH; Adrian TE
Biochem Biophys Res Commun; 1999 Dec; 266(2):392-9. PubMed ID: 10600514
[TBL] [Abstract][Full Text] [Related]
6. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818
[TBL] [Abstract][Full Text] [Related]
7. Enhancing antitumor effects in pancreatic cancer cells by combined use of COX-2 and 5-LOX inhibitors.
Ding X; Zhu C; Qiang H; Zhou X; Zhou G
Biomed Pharmacother; 2011 Oct; 65(7):486-90. PubMed ID: 21993002
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 5-lipoxygenase triggers apoptosis in pancreatic cancer cells.
Zhou GX; Ding XL; Wu SB; Zhang HF; Cao W; Qu LS; Zhang H
Oncol Rep; 2015 Feb; 33(2):661-8. PubMed ID: 25483364
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.
Martel-Pelletier J; Mineau F; Fahmi H; Laufer S; Reboul P; Boileau C; Lavigne M; Pelletier JP
Arthritis Rheum; 2004 Dec; 50(12):3925-33. PubMed ID: 15593193
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors.
Li M; Yang H; Chai H; Fisher WE; Wang X; Brunicardi FC; Yao Q; Chen C
Cancer; 2004 Nov; 101(10):2341-50. PubMed ID: 15476280
[TBL] [Abstract][Full Text] [Related]
11. Suppression of 5-lipoxygenase gene is involved in triptolide-induced apoptosis in pancreatic tumor cell lines.
Zhou GX; Ding XL; Huang JF; Zhang H; Wu SB
Biochim Biophys Acta; 2007 Jul; 1770(7):1021-7. PubMed ID: 17434678
[TBL] [Abstract][Full Text] [Related]
12. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenases and lipoxygenases as potential targets for treatment of pancreatic cancer.
Ding XZ; Tong WG; Adrian TE
Pancreatology; 2001; 1(4):291-9. PubMed ID: 12120207
[TBL] [Abstract][Full Text] [Related]
14. Kif20a inhibition reduces migration and invasion of pancreatic cancer cells.
Stangel D; Erkan M; Buchholz M; Gress T; Michalski C; Raulefs S; Friess H; Kleeff J
J Surg Res; 2015 Jul; 197(1):91-100. PubMed ID: 25953216
[TBL] [Abstract][Full Text] [Related]
15. 5-Lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions.
Hennig R; Grippo P; Ding XZ; Rao SM; Buchler MW; Friess H; Talamonti MS; Bell RH; Adrian TE
Cancer Res; 2005 Jul; 65(14):6011-6. PubMed ID: 16024599
[TBL] [Abstract][Full Text] [Related]
16. Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model.
Ding X; Zhou X; Zhang H; Qing J; Qiang H; Zhou G
Cancer Chemother Pharmacol; 2012 Jan; 69(1):253-61. PubMed ID: 21713446
[TBL] [Abstract][Full Text] [Related]
17. 5-Lipoxygenase contributes to the progression of hepatocellular carcinoma.
Xu XM; Deng JJ; Yuan GJ; Yang F; Guo HT; Xiang M; Ge W; Wu YG
Mol Med Rep; 2011; 4(6):1195-200. PubMed ID: 21833474
[TBL] [Abstract][Full Text] [Related]
18. Expression of 12-lipoxygenase in human renal cell carcinoma and growth prevention by its inhibitor.
Yoshimura R; Inoue K; Kawahito Y; Mitsuhashi M; Tsuchida K; Matsuyama M; Sano H; Nakatani T
Int J Mol Med; 2004 Jan; 13(1):41-6. PubMed ID: 14654968
[TBL] [Abstract][Full Text] [Related]
19. Expression of 5-lipoxygenase (5-LOX) in T lymphocytes.
Cook-Moreau JM; El-Makhour Hojeij Y; Barrière G; Rabinovitch-Chable HC; Faucher KS; Sturtz FG; Rigaud MA
Immunology; 2007 Oct; 122(2):157-66. PubMed ID: 17484769
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells.
Tong WG; Ding XZ; Talamonti MS; Bell RH; Adrian TE
Anticancer Drugs; 2007 Jun; 18(5):535-41. PubMed ID: 17414622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]